Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,377
Recruiting: 745
Ph III recruiting: 79
Growth YoY: +22.3%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 251–300 of 1,866 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04751929	Abemaciclib With or Without Atezolizumab for mCRPC	completed	Phase 2	19	Dana-Farber Cancer InstituteOTHER	1	Jun 17, 2026	clinicaltrials
NCT01950351	Hypofractionated Proton Beam Therapy for Localized Prostate Cancer	active not recruiting	Phase 2	241	M.D. Anderson Cancer CenterOTHER	1	Jun 16, 2026	clinicaltrials
NCT05790213